The National Assessment and Decision-making Model for Medicines Will be Developed Gradually by 2029
Finland is currently developing a national assessment and decision-making model for medicines.
Risk-Sharing Agreements in Finland
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish Market Access scene at the moment. Medaffcon has been studying the agreements, their application and experiences in using them and has also been participating in building several risk-sharing agreements in Finland, both in ambulatory care (with Pharmaceutical Pricing Board) and hospital care (with hospitals).
Learn more about RSA’s from the interview with Pekka Männistö from the video below.
Read more about Market Access of medicines in Finland:
Market Access, pricing and reimbursement of medicines in Finland – This article provides information of the market access options and current pricing system in Finland, in ambulatory and hospital care.
